Cargando…
Calcitriol treatment in metabolic bone disease of prematurity with elevated parathyroid hormone: A preliminary study
OBJECTIVE: To describe the association of calcitriol treatment with the change in parathyroid hormone (PTH) and biochemical markers of bone disease in infants with metabolic bone disease of prematurity (MBD) and secondary hyperparathyroidism. STUDY DESIGN: This retrospective chart review examined se...
Autores principales: | Rustico, Stacy E., Kelly, Andrea, Monk, Heather M., Calabria, Andrew C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685017/ https://www.ncbi.nlm.nih.gov/pubmed/29159104 http://dx.doi.org/10.1016/j.jcte.2014.12.001 |
Ejemplares similares
-
Metabolic bone disease of prematurity()
por: Rustico, Stacy E., et al.
Publicado: (2014) -
Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
por: Brito Galvao, Joao F, et al.
Publicado: (2013) -
Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
por: Cheng, Qun, et al.
Publicado: (2018) -
Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism
por: Xiang, Zeli, et al.
Publicado: (2022) -
Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial
por: Hassoon, Ahmed, et al.
Publicado: (2018)